Karthikeyan, A.; Young, K.N.; Moniruzzaman, M.; Beyene, A.M.; Do, K.; Kalaiselvi, S.; Min, T.
Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021, 13, 484.
https://doi.org/10.3390/pharmaceutics13040484
AMA Style
Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T.
Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics. 2021; 13(4):484.
https://doi.org/10.3390/pharmaceutics13040484
Chicago/Turabian Style
Karthikeyan, Adhimoolam, Kim Na Young, Mohammad Moniruzzaman, Anteneh Marelign Beyene, Kyoungtag Do, Senthil Kalaiselvi, and Taesun Min.
2021. "Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook" Pharmaceutics 13, no. 4: 484.
https://doi.org/10.3390/pharmaceutics13040484
APA Style
Karthikeyan, A., Young, K. N., Moniruzzaman, M., Beyene, A. M., Do, K., Kalaiselvi, S., & Min, T.
(2021). Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics, 13(4), 484.
https://doi.org/10.3390/pharmaceutics13040484